ACAAI 2025 | CS2015 (OX40L/TSLP Bispecific Antibody) Makes International Debut
PR Newswire —
SUZHOU, China, Nov. 6, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone," HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, autoimmune/inflammation, and other key disease areas, today announced that the...